Latest News and Press Releases

Novotech today published the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.

Novotech, the leading Asia Pacific-centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as CMO.

BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in...

SINGAPOUR, 14 juill. 2023 (GLOBE NEWSWIRE) -- Novotech, la principale CRO en biotechnologie centrée sur l'Asie-Pacifique dont les capacités d'exécution sont mondiales, est finaliste pour les Prix de...

SINGAPUR, July 14, 2023 (GLOBE NEWSWIRE) -- Novotech, das führende, auf den asiatisch-pazifischen Raum ausgerichtete Auftragsforschungsinstitut im Bereich der Biotechnologie mit globalen...

SINGAPORE, July 13, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy...

SEOUL, Korea, July 10, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities will present a technical session at BIOPLUS-INTERPHEX KOREA...

BOSTON, May 29, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with...

SYDNEY, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their...

SINGAPORE, March 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical-stage biotechs and to share the...